Ian Mortimer
Chief Executive Officer presso XENON PHARMACEUTICALS INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Posizioni attive di Ian Mortimer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| XENON PHARMACEUTICALS INC. | Director/Board Member | 03/06/2021 | - |
| Chief Executive Officer | 03/06/2021 | - | |
| President | 12/03/2018 | - | |
| Chief Operating Officer | 12/03/2015 | 12/03/2018 | |
| Director of Finance/CFO | 21/10/2013 | 03/06/2021 | |
| Investor Relations Contact | 21/10/2013 | - | |
| Corporate Secretary | 01/06/2015 | 03/06/2021 | |
| PERIMETER MEDICAL IMAGING AI, INC. | Director/Board Member | 03/07/2020 | - |
Xenon Pharmaceuticals USA, Inc.
 Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Director/Board Member | - | - |
| President | - | - | |
| Treasurer | - | - |
Storia della carriera di Ian Mortimer
Precedenti posizioni note di Ian Mortimer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Director of Finance/CFO | 01/01/2004 | 01/10/2013 |
Perimeter Medical Imaging, Inc.
 Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada. | Director/Board Member | 03/07/2020 | - |
| APPILI THERAPEUTICS INC. | Director/Board Member | 28/11/2017 | 27/01/2020 |
| Chairman | 27/01/2020 | - | |
| Independent Dir/Board Member | 28/11/2017 | - |
Formazione di Ian Mortimer
| Queen's University | Masters Business Admin |
| University of British Columbia | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Canada | 7 |
| Stati Uniti | 3 |
Posizioni
| Director/Board Member | 5 |
| Director of Finance/CFO | 2 |
| President | 2 |
Settori
| Health Technology | 7 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| APPILI THERAPEUTICS INC. | Health Technology |
| PERIMETER MEDICAL IMAGING AI, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Perimeter Medical Imaging, Inc.
Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada. | Health Technology |
Xenon Pharmaceuticals USA, Inc.
Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Health Technology |
- Borsa valori
- Insiders
- Ian Mortimer
- Esperienza
